Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis
Hematological Oncology · 2024
DOI: 10.1002/hon.3270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematological Oncology, 2024. Verfasst von Maria Livia Del Giudice und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Amyloidosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Light chain amyloidosis is a rare disease caused by clonal plasma cells in the bone marrow generating an excessive amount of immunoglobulin light chains. These chains misfold and produce insoluble fibrils that deposit in various organs, including the heart, kidneys, liver, nervous system, and digestive tract. Life expectancy and symptoms during the course of the disease vary depending on which and how many organs are affected. Targeted plasma cell therapy has significantly advanced the clinical management of amyloidosis, with ongoing progress. However, current clinical studies are investigating innovative targets, drug combinations and treatment strategies to improve therapeutic outcomes by minimizing adverse effects and refining patient prognosis in these challenging hematological conditions. In this paper, we review the state of the art regarding the use of anti‐amyloid antibodies, as a revolutionary and innovative approach in the current scenario of amyloid treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy.
ORCID-Profile: Maria Livia Del Giudice, Sara Galimberti
Zitieren
APA
Del Giudice, M. L., Galimberti, S., & Buda, G. (2024). Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis. Hematological Oncology. https://doi.org/10.1002/hon.3270
Vancouver
Del Giudice ML, Galimberti S, Buda G. Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis. Hematological Oncology. 2024. doi:10.1002/hon.3270
BibTeX
@article{DelGiudice2024,
author = {Del Giudice, Maria Livia and Galimberti, Sara and Buda, Gabriele},
title = {Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis},
journal = {Hematological Oncology},
year = {2024},
doi = {10.1002/hon.3270}
}
EUVIMED